Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2015 Jun 23;112(27):E3485–E3494. doi: 10.1073/pnas.1503955112

Structural analysis of a class III preQ1 riboswitch reveals an aptamer distant from a ribosome-binding site regulated by fast dynamics

Joseph A Liberman a, Krishna C Suddala b,c, Asaminew Aytenfisu a, Dalen Chan d, Ivan A Belashov a, Mohammad Salim a, David H Mathews a, Robert C Spitale d, Nils G Walter b, Joseph E Wedekind a,1
PMCID: PMC4500280  PMID: 26106162

Significance

Riboswitches are RNA molecules found mostly in bacteria that control genes by sensing cellular levels of metabolites, such as the simple organic compound preQ1. The diversity of riboswitches and their potential as novel antibiotic targets continue to elicit interest in these regulatory sequences. Here we present the crystal structure of a newly discovered bacterial preQ1-III riboswitch that senses preQ1 using an unusual, two-part architecture. A complementary analysis of flexibility and dynamics showed that recognition of preQ1 induces riboswitch compaction, while concomitantly enhancing formation of a distant double-helix possessing a regulatory signal that zips and unzips rapidly, producing gene “off” and “on” states. These observations expand our knowledge of riboswitch construction and suggest a broader role for dynamics than previously recognized.

Keywords: preQ1 riboswitch, gene regulation, crystal structure, single-molecule FRET, molecular dynamics

Abstract

PreQ1-III riboswitches are newly identified RNA elements that control bacterial genes in response to preQ1 (7-aminomethyl-7-deazaguanine), a precursor to the essential hypermodified tRNA base queuosine. Although numerous riboswitches fold as H-type or HLout-type pseudoknots that integrate ligand-binding and regulatory sequences within a single folded domain, the preQ1-III riboswitch aptamer forms a HLout-type pseudoknot that does not appear to incorporate its ribosome-binding site (RBS). To understand how this unusual organization confers function, we determined the crystal structure of the class III preQ1 riboswitch from Faecalibacterium prausnitzii at 2.75 Å resolution. PreQ1 binds tightly (KD,app 6.5 ± 0.5 nM) between helices P1 and P2 of a three-way helical junction wherein the third helix, P4, projects orthogonally from the ligand-binding pocket, exposing its stem-loop to base pair with the 3′ RBS. Biochemical analysis, computational modeling, and single-molecule FRET imaging demonstrated that preQ1 enhances P4 reorientation toward P1–P2, promoting a partially nested, H-type pseudoknot in which the RBS undergoes rapid docking (kdock ∼0.6 s−1) and undocking (kundock ∼1.1 s−1). Discovery of such dynamic conformational switching provides insight into how a riboswitch with bipartite architecture uses dynamics to modulate expression platform accessibility, thus expanding the known repertoire of gene control strategies used by regulatory RNAs.


Riboswitches are structured RNA motifs that sense the cellular levels of small molecules to provide feedback regulation of genes (1). Although present in all domains of life, they are prominent in bacteria where they typically reside in the 5′-leader sequences of mRNA (2). Broad interest in riboswitches originates from the discovery that they can be targeted by antimicrobials (35), and the observation that they use complex scaffolds to achieve gene regulation without the need for protein partners. In the latter respect, riboswitches typically exhibit bipartite sequence organization comprising a conserved aptamer linked to a downstream expression platform (2). Aptamer binding to a cognate effector can induce conformational changes that alter the accessibility of expression platform sequences, such as those required for transcriptional read-through, or hybridization to the 16S rRNA as a preface to translation (2, 6).

Numerous riboswitches fold as pseudoknots that conform to the H-type or closely related HLout-type topology, which have emerged as the most efficient RNA scaffolds to integrate aptamer and expression platform sequences (7). The preQ1-I, preQ1-II, S-adenosyl-l-methionine-II (SAM-II), and fluoride riboswitches are representative of this organizational strategy, and their analysis has contributed to a renaissance in our understanding of regulatory pseudoknot structure and dynamics (818). By contrast, pseudoknotted aptamers that do not integrate their expression platforms are less common, and this added complexity can encumber efforts to elucidate how ligand-induced conformational changes regulate gene expression. Such riboswitches include the cyclic-di-adenosine monophosphate, SAM-IV, and SAM-I/IV riboswitches (1922), as well as the recently identified preQ1-III riboswitch (23).

The discovery of a third class of preQ1 riboswitches makes this ligand second only to SAM in terms of the number of riboswitches that respond to this effector (23), underscoring the importance of sensing this molecule within the cell (6). PreQ1 is the last free intermediate on the queuosine (Q) anabolic pathway (Fig. 1A). Q is produced exclusively in bacteria (24) where it is incorporated into tRNAs Asn, Asp, His, and Tyr to confer translational fidelity (2528). Many eukaryotes require Q but attain it as the base queuine from gut flora or diet (29); its deficiency in germ-free mice compromises tyrosine production (30). In bacteria, Q elimination diminishes growth fitness in stationary phase (24), and can contribute to virulence loss (31). At present, the preQ1-III riboswitch has been identified in a handful of Ruminococcaceae with the preponderance of sequences originating from metagenomes (23). The proximity of the aptamer to a downstream RBS preceding the queT start codon suggests a role in translational regulation comparable to many class I, and all class II preQ1 riboswitches (23, 32, 33). However, at ∼100 nucleotides in length, the preQ1-III riboswitch is substantially larger than other family members, which exhibit more diminutive sizes ranging from 33 to 58 nucleotides. Moreover, the preQ1-III aptamer domain is confined to an atypically organized HLout-type pseudoknot that does not appear to incorporate its downstream expression platform. Biochemical analysis has not identified the location or mode of preQ1 binding, and the backbone flexibility of both RBS and anti-RBS sequences did not modulate appreciably as a function of preQ1 concentration (23), unlike class I and II preQ1 riboswitches that show clear preQ1-dependent RBS sequestration (16, 18, 32, 33).

Fig. 1.

Fig. 1.

Queuosine biosynthesis, secondary structure, and overall fold of the ligand-bound preQ1-III riboswitch. (A) Biosynthesis of the hypermodified nucleotide queuosine (Q) begins with GTP and leads to the intermediate preQ1 via enzymes of the queCDEF operon, which is regulated by a preQ1-I riboswitch in some bacteria (33). PreQ1 is then inserted at the wobble position of specific tRNAs with additional modifications added in situ (the complete pathway is reviewed in ref. 52). A scavenging pathway has been proposed wherein Q-related molecules are imported by the queT (COG4708) gene product (32), which is regulated in some bacteria by class I, II, and III preQ1 riboswitches. (B) Secondary structure of the wild-type F. prausnitzii riboswitch based on the crystal structure. PreQ1 is green, junctions are labeled J, and pairing regions (P) are color-coded; long-range interactions are indicated by dashed lines. A boxed sequence (gray) near P3 indicates the sequence used to produce a phasing module (PM) (53). The RBS sequence 5′-CGGAG-3′ is highlighted (yellow). The assigned secondary structure differs subtly from comparative sequence analysis (23) because the U17•A84 interaction is not a canonical pair. The sym label indicates the crystallographic domain-swapping interaction that resembles bioinformatically predicted helix P5. (C) Cartoon of the preQ1-bound crystal structure preserving colors from B; preQ1 is depicted as a semitransparent surface model. The RBS sugar and base rings are yellow. (Inset) View from C rotated 90° about the y axis. (D) Coaxial stacking of P1 with the proximal end of helix P3, and depiction of P3 to J3-4 tertiary contacts.

To elucidate the molecular basis for ligand recognition and translational regulation by the class III preQ1 riboswitch, we determined the crystal structure of the intact sensing domain from Faecalibacterium prausnitzii in complex with preQ1 at 2.75 Å resolution. We used isothermal titration calorimetry (ITC), chemical modification (selective 2′-hydroxyl acylation analyzed by primer extension, or SHAPE), computational modeling, and single-molecule FRET (smFRET) analyses to relate the atomic-level details of ligand binding to conformational dynamics. Our results show how preQ1 binding within an atypically organized HLout-type pseudoknot can promote a globally compact fold. This conformation increases the population of molecules competent to form a second downstream pseudoknot, wherein the RBS docks dynamically within a helix distal to the aptamer domain. The discovery of such rapidly interconverting conformational states broadens our understanding of regulatory RNA structure, and supports a new role for dynamics in riboswitch-mediated control of protein translation.

Results

Ligand Binding and Bipartite Organization of the PreQ1-III Riboswitch Structure.

The F. prausnitzii riboswitch of this investigation comprises 101 nucleotides of the wild-type sequence encompassing the predicted 5′ pseudoknot and the 3′ RBS (23) (Fig. 1B). This construct binds preQ1 with an apparent KD of 6.5 ± 0.5 nM and a binding stoichiometry of 1:1 (Table S1 and Fig. S1A; Methods and SI Methods). These results are comparable to values measured for class I and II family members, which produced apparent KD values of 7.3 nM and 17.9 nM, respectively, and showed similar 1:1 binding stoichiometry (11, 18). Crystals of the 101-mer were grown from organic salts at neutral pH and the phase problem was overcome by single-isomorphous replacement with anomalous scattering; the initial structure was then refined to 2.75 Å resolution to acceptable Rfactor and geometry values (Table 1). The global tertiary fold is λ-shaped with dimensions of 92 × 80 × 32 Å (Fig. 1C). The aptamer is composed of contributions from four pairing regions, P1–P4 (Fig. 1 B and C), organized as a HLout-type pseudoknot wherein P3 and P4 reside in extended loop, L3, located in the 3′ tail (Fig. S2A). P1 is longer than predicted (23) because consecutive purines form trans Watson–Crick pairs that extend this helix (Fig. 1 B and C). This conserved feature allows P1 insertion between P2 and P3, forming a coaxial stack that becomes continuous when preQ1 binds in the pocket formed by the P1–P2–P4 helical junction (Fig. 1 B and C). The stacked P1–P3 feature (Fig. 1D) clarifies why mutations that disrupted the proximal end of P3 led to reduced ligand affinity, whereas distal mutations within this helix showed only nominal effects (23). P4 projects orthogonally from the P2–P1–P3 coaxial stack, forming a 43-Å-long helix whose stem-loop is complementary in sequence to the 3′ terminus of the riboswitch (Fig. 1 B and C). However, rather than engaging in the 7-bp helix predicted by bioinformatics (23), the P4 stem-loop pairs intermolecularly (Fig. 1B). This domain-swapped interaction appears to have facilitated crystallization and mimics aspects of the predicted intramolecular RBS base pairing interaction believed to be operative in gene regulation (23) (see below).

Table S1.

PreQ1-III riboswitch ligand affinity and thermodynamic parameters

Sample name KD, nM n, no. of binding sites ΔH, kcal⋅mol−1 −TΔS, kcal⋅mol−1 ΔG, kcal⋅mol−1 ΔΔG, kcal⋅mol−1*
Fpr wild type 6.5 ± 0.5 0.94 ± 0.004 −26.8 ± 0.2 15.8 ± 0.2 −11.0 ± 0.04 n/a
env 74 split seq 10.1 ± 2.5 0.98 ± 0.01 −34.1 ± 0.3 23.1 ± 0.2 −10.9 ± 0.2 n/a
env 74 s2Δ30–43 4.6 ± 0.2 1.12 ± 0.01 −31.3 ± 0.8 19.9 ± 0.8 −11.4 ± 0.002 −0.5
Fpr wild type 0.5 mM EDTA 17.0 ± 1.7 0.64 ± 0.01 −85.9 ± 0.3 75.5 ± 0.2 −10.4 ± 0.05 +0.6
Fpr C7U§ 83.3 ± 1.0 0.89 ± 0.14 −24.8 ± 3.6 15.3 ± 3.6 −9.5 ± 0.01 +1.5
Fpr U17C§, 2023 ± 773 0.29 ± 0.05 −26.8 ± 1.3 19.1 ± 1.5 −7.7 ± 0.2 +3.3
Fpr A52G§ 4.0 ± 0.4 1.12 ± 0.02 −22.8 ± 0.2 11.5 ± 0.2 −11.3 ± 0.1 −0.3
Fpr A84G§ 27.2 ± 1.7 1.07 ± 0.01 −27.2 ± 1.7 17.1 ± 1.9 −10.2 ± 0.2 +0.8

Values are the mean and SD from two or more independent experiments. All titrations were conducted in the presence of 6 mM Mg2+, except those conducted in the presence of 0.5 mM EDTA. The temperature was 20 °C for all experiments, except for split sequences, which were examined at 25 °C.

*

Calculated relative to the wild-type 101-mer, or the split sequence for s2Δ30–43.

Sequence in Fig. S4A.

Described in Fig. S4A, but bases from 30 to 43 were deleted in strand 2 (s2Δ30–43) to show that domain-swapping and the 3′-tail past P2 are not required for preQ1 binding. A similar deletion experiment was performed for the Fpr preQ1-III riboswitch that also revealed no significant change in preQ1 affinity (23), thus demonstrating the dispensability of this region in preQ1 recognition.

§

Mutation was conducted in the context of the Fpr wild-type 101-mer sequence (Fig. 1B).

Mutation likely caused some misfolding based on the low binding stoichiometry.

Fig. S1.

Fig. S1.

Representative ITC experiments for preQ1 binding to preQ1-III riboswitches. Apparent KD, stoichiometry values (n), and c values for individual experiments are shown; average values are provided in Table S1. (A) PreQ1 binding to the wild-type Fpr preQ1-III riboswitch 101-mer (Fig. 1B) in a buffer containing 0.050 M Na–Hepes (pH 7.0), 0.10 M NaCl, 0.006 M MgCl2; Methods. (B) PreQ1 binding to the split 74 env preQ1-III riboswitch (Fig. S4A). (C) PreQ1 binding to the 74 env preQ1-III riboswitch in which the 3′ end was removed after P2 (s2Δ30–43). (D) PreQ1 binding to the wild-type Fpr preQ1-III riboswitch, except 0.5 mM EDTA was substituted for MgCl2 in the buffer used in A. (E) PreQ1 binding to the C7U mutant in the context of the Fpr wild-type riboswitch under conditions described in A. (F) PreQ1 binding to the Fpr U17C mutant as in A. (G) PreQ1 binding to the Fpr A52G mutant as in A. (H) PreQ1 binding to the Fpr A84G mutant as in A. (I) IXP does not bind appreciably to the wild-type preQ1-III riboswitch under conditions in A. (J) 2AP does not bind appreciably to the preQ1-III riboswitch under buffer conditions described in A. The slightly positive slope of the curve fit could be the result of very weak binding consistent with observations on the wild-type preQ1-II riboswitch, which shows an apparent KD for 2AP that is ∼3 log units poorer than that for preQ1 (32).

Table 1.

PreQ1-III X-ray diffraction and refinement statistics

Samples PM (native) PM (0.1 M CsCl) Wild-type (refinement)
Data collection*
 Wavelength, Å 1.0000 1.7000 1.1696
 Space group P6522 P6522 P6522
 Cell constants
  a = b, c, Å 83.7, 278.7 83.8, 279.8 84.1, 278.4
  α = β, γ, ° 90.0, 120.0 90.0, 120.0 90.0, 120.0
 Resolution (Å) 41.40–3.00 44.30–3.00 39.20–2.75
(3.10–3.00) (3.10–3.00) (2.90–2.75)
Rp.i.m. (%) 4.5 (11.7) 3.0 (11.9) 3.9 (97.8)
 CC1/2 (%) 99.7 (97.6) 99.9 (99.6) 99.9 (58.0)
I/σ(I) 15.6 (2.3) 22.9 (2.7) 16.6 (0.9)
 Complete (%) 98.8 (93.8) 96.0 (74.5) 97.1 (99.1)
 Redundancy 8.0 (7.5) 18.8 (8.0) 3.0 (3.1)
Refinement statistics
  Resolution, Å 38.3–2.75
  No. reflections 14,702
  Rwork/Rfree, % 21.2/22.8
 No. atoms
  RNA 2,119
  Ligand 13
  Water 4
B-factors, Å2
  RNA 122
  Ligand 60
  Water 90
 Rmsd
  Bonds, Å 0.002
  Angles, ° 0.55
 Clash score§ 1.24
 Coord. error, ŧ 0.46
*

X-ray data collection was conducted remotely at the SSRL using Blu-Ice software and the Stanford Auto-Mounter (48).

Rprecision-indicating merging R-value = hkl1N1i=1N|l(hkl)<l(hkl)>|hkli=1Nl(hkl), where N is the redundancy of the data and <I(hkl)> is the average intensity (49).

The Pearson correlation coefficient calculated for the average intensities resulting from division of the unmerged data into two parts, each containing half of the measurements selected at random for each unique reflection (50).

§

As implemented in PHENIX (51).

Fig. S2.

Fig. S2.

Pseudoknot classification of various preQ1 riboswitches. The diagrams and classifications are based on established nomenclature (70) in which stem (S) or loop (L) regions are depicted as paired nucleotides (open circles) joined by a short black line, or single-stranded segments (closed circles). A green oval indicates the location of preQ1 binding, which pairs with L1 and L2 and can generate an L2 = 0 configuration that yields coaxial helical stacking of S1 and S2. Bases of the RBS are highlighted (yellow). (A) The preQ1-III riboswitch 5′ HLout-type pseudoknot based on the crystal structure (Fig. 1C). The organization is comparatively atypical because of the extended nature of the L3 loop, which encompasses (i) the stem-loop subsequent to S1 (i.e., P3 in Fig. 1 B and C), (ii) a loop of four nucleotides, (iii) a second stem-loop (i.e., P4 of Fig. 1 B and C), and (iv) an unpaired loop of two nucleotides that precedes the second strand of stem S2. (B) The preQ1-I riboswitch folds as a simple H-type pseudoknot; base pairing was derived from the crystal structures (9, 13). (C) The preQ1-II riboswitch forms a classical HLout-type pseudoknot in which the entire RBS is sequestered in stem S2 (12, 18).

Ligand Recognition Uses Base Triples and Inclined A-Minor Interactions.

PreQ1 binding occurs within the P1–P2–P4 helical junction at the P1–P2 interface, stitched together by J1-2 and J2-1 (Fig. 2A). The closing P1 pair, A6•A18, forms the “ceiling” of the binding pocket, and the U8•A85-U16 triplex serves as the floor. The quality of the riboswitch model is demonstrated by the fit of preQ1 into electron density maps that define its orientation and chemical contacts, including a hydrogen bond and salt bridge to the preQ1 methylamine moiety from O2 of U8 and the pro-Rp nonbridging oxygen of A85 (Fig. 2B and Fig. S3A). Junction nucleotides contribute a belt of equatorial interactions to the effector. C7 of J1-2 forms a trans Watson–Crick interaction with the guanine-like face of preQ1, whereas U17 of J2-1 engages the “minor groove” edge (Fig. 2 A and B). The A52 and A84 N1 imines accept hydrogen bonds from the 2′-OH groups of A85 and U17 (Fig. 2 A and B). These inclined A-minor interactions originate from the extended 3′ tail of the HLout-type pseudoknot and provide base stacking interactions that buttress the binding-pocket floor and ligand, respectively (Fig. 2 A and B). With regard to the floor, prior bioinformatic and biochemical analyses predicted P2 formation with caution due to its lack of covariation and A-U richness (23). These attributes are explained by the structure because bases U8 through A10 of J1-2 form major-groove triplexes with the Hoogsteen edges of bases A85–A87, stabilizing the P2 helix while fortifying the pocket floor (Fig. 2C). The identification of consecutive U•A-U triples in the structure also explains why prior U14-A87 and U15-A86 transversion mutations lowered preQ1 affinity (23). Overall, the quadruple triplex motif provides a stable, flat surface to recognize the mostly planar preQ1 ligand, whose presence is integral to the formation of a stable P2–P1–P3 coaxial stack (Fig. 1 B and C and Fig. S2A).

Fig. 2.

Fig. 2.

Details of the preQ1-binding pocket within a three-helix junction. (A) Close-up view of the P1–P2–P4 helical junction that binds preQ1. The “ceiling” exhibits tandem purine base pairs emanating from P1. PreQ1 resides in the center of a base triple-flanked by C7 and U17. Stacked bases A84 and A52 make respective N1-imino to 2′-hydroxyl group interactions with U17 and A85; the latter base stacks below preQ1 as part of the U•A-U triplex that composes the pocket “floor.” (B) Close-up view of the preQ1-binding site depicting the final refined ligand bathed in unbiased (average kicked) mFo–DFc electron density at the 3.0 σ level. Ligand-specific readout by C7 and U17 is shown in the context of the U8•A85 Hoogsteen pair that forms the floor. The A85 phosphate group and O2 keto of U8 make complementary interactions to the 7-aminomethyl moiety of preQ1, providing additional specificity. ΔΔG (kcal⋅mol-1) values relative to wild type are shown for various mutations tested for ligand binding (Table S1). The view is rotated ∼180° about the y axis relative to Fig. 1C. (C) Major-groove base-triple pairing of J1-2 with P2 under the preQ1-binding pocket; tandem U•A-U triples are flanked by a single A10•A87-U14 triplex.

Fig. S3.

Fig. S3.

Representative electron-density maps and crystallographic symmetry interactions of the Fpr preQ1-III riboswitch. (A) Stereoview of the preQ1-binding site with the final refined structure shown within unbiased, composite iterative-build omit electron density (71) at 2.75 Å resolution; the contour levels are 1.0 σ (blue) and 7.0 σ (green). (B) The 3.0-Å resolution experimental electron density map contoured at 1.0 σ based on the initial density-modified SIRAS phases; a cartoon of the final refined coordinates (Fig. 1C) is included. (C) The final 2.75-Å resolution, reduced-bias (σA-weighted) 2mFo–DFc electron density map contoured at 1.0 σ using phases from the final refined model included as a ribbon diagram (Fig. 1C). Nucleotides 34 and 35 located in the P3 loop (Top) exhibited poor electron density and were not included in the final model. (D) Ribbon diagram depicting the dyad (filled oval) crystallographic contacts that compose the intermolecular, “domain swapped” region of helix P5. The RBS is labeled and comprises the last five nucleotides of the 3′ terminus. (E) Magnified view of suboptimal, intermolecular helix P5 from D (dashed box). Only the first three bases of the RBS are depicted for clarity (yellow base and ribose planes). Base pairing begins with a 71U•92U noncanonical pair, followed by five Watson–Crick base pairs ending at the 66G-97C pair, which encompasses the first base of the RBS. (Lower) The suboptimal pairing of P5 is depicted as a secondary structure with the RBS highlighted (yellow). (F) Stereoview showing three symmetry-related molecules in the lattice (blue, purple, and green) emphasizing the absence of crystal contacts at the binding site for preQ1, depicted as a space-filling model (green). All cartoon diagrams of the structure were produced using PyMOL (Schrödinger, LLC).

Base Triples of the PreQ1-III Aptamer Exhibit Similarities to the Ligand-Recognition Motifs of Other Riboswitches.

Use of major-groove base triples for effector recognition is a molecular motif that the preQ1-III riboswitch shares with a handful of other regulatory RNAs. The preQ1-II and preQ1-III riboswitches recognize preQ1 by using a common constellation of bases and underlying U•A-U triplexes that superimpose with an rmsd of 1.1 Å (Fig. 3A). A notable difference in this comparison is that the hydrogen-bonding pattern between N1 of preQ1 and the Watson–Crick face of C8 in the preQ1-II riboswitch is consistent with bifurcation (12). This mode of imine hydrogen bonding by the ligand is not evident in the preQ1-III structure, and appears to be a source of positional differences in the respective structures (Fig. 3A). Interestingly, the SAM-II riboswitch uses a similar array of major-groove triples to recognize the adenine moiety of SAM (8) (Fig. 3B); these nucleotides superimpose on the triplexes of the preQ1-III riboswitch with an rmsd of 0.82 Å. SAM overlaps U17 of the preQ1-III riboswitch in the C7•preQ1•U17 triplet, whereas preQ1 overlaps U44 of the U10•U44•SAM triplet. Beyond variations in the ligand-recognition triplex, the underlying U•A-U triples of the preQ1-II, preQ1-III, and SAM-II riboswitches show substantial spatial similarity (Fig. 3 A and B). The cyclic-di-guanosine-monophosphate-II (c-di-GMP-II) riboswitch also uses major-groove triples to bind the guanine bases of its ligand (34), and produces a local superposition of 2.0 Å compared with the preQ1-III riboswitch (Fig. 3C). This degree of structural homology is noteworthy given the fact that these riboswitches do not share any common bases in this region. In light of the distinct evolutionary origins and diverse tertiary folds of the riboswitches examined here, this analysis highlights the resilience and versatility of triplexes in the recognition of nucleobase ligands, which should facilitate prediction of regulatory RNA function based on sequence.

Fig. 3.

Fig. 3.

Comparison of the preQ1-III riboswitch to other regulatory RNAs that use triplexes to recognize nucleobase ligands. (A) Overlay of the preQ1-III riboswitch base triples (gold) upon the preQ1-II riboswitch (deep purple; PDB ID code 2MIY) (12). The superposition is based on the major-groove base triples and preQ1, which yielded an average rmsd of 1.1 Å. Here and elsewhere, the preQ1-III riboswitch ligand is green, and the superimposed ligand is magenta. (B) Overlay of the preQ1-III riboswitch base triples upon those of the SAM-II riboswitch (deep purple; PDB ID code 2QWY) (8). The superposition is based on shared major-groove base triplex nucleotides (excluding ligand), which yielded an average rmsd of 0.82 Å. (C) Overlay of the preQ1-III riboswitch base triples with those of the c-di-GMP-II riboswitch (deep purple; PDB ID code 3Q3Z) (34). The superposition is based on shared nucleotide atoms (excluding ligand), which yielded an average rmsd of 2.0 Å.

Thermodynamic Analysis of PreQ1 Binding-Site Mutants Supports the Observed Mode of Ligand Recognition.

To evaluate the thermodynamics of folding, divalent ion requirements, and to validate the structural basis of preQ1 recognition by the preQ1-III riboswitch, we conducted a series of binding experiments in solution using ITC. Effector binding by the preQ1-ΙΙΙ riboswitch is enthalpy driven with a ΔH of −26.8 ± 0.2 kcal⋅mol−1, which more than offsets the unfavorable entropy of 15.8 ± 0.2 kcal⋅mol−1 (Table S1). Prior in-line probing experiments on the wild-type Fpr riboswitch sequence used in this investigation (23), as well as ITC analysis on a second, minimal preQ1-III riboswitch, env 74 (Fig. S4A), indicated that the 3′ tail of the riboswitch is dispensable past P2 for preQ1 binding (Table S1 and Fig. S1 B and C); these results agree with the crystal structure wherein the 3′ terminus is not involved in aptamer formation. Site-bound divalent metal ions were not observed in the preQ1-III crystal structure, and the riboswitch binds preQ1 in the absence of Mg2+, albeit with a reduction of affinity by a factor of three, and a substoichiometric n value of 0.64 (Table S1 and Fig. S1D). These observations imply that divalent ions are important for proper preQ1-III riboswitch folding, which could be the underlying cause of reduced ligand recognition. We then analyzed various mutants of specific nucleobases observed in the structure to be important for preQ1 binding. C7U yielded a ΔΔG of 1.5 kcal⋅mol−1 compared with wild type, suggesting one or two lost hydrogen bonds in accord with the structure (Fig. 2B, Fig. S1E, and Table S1). U17C produced a ΔΔG of 3.3 kcal⋅mol−1 (Fig. S1F and Table S1), implying two or three lost hydrogen bonds to preQ1, which also concurs with the structure (Fig. 2B). The inclined A-minor bases A52 and A84 do not hydrogen bond directly to preQ1 and, accordingly, the respective A-to-G mutations showed smaller ΔΔG values of −0.3 kcal⋅mol−1 and 0.8 kcal⋅mol−1 (Fig. 2B, Table S1, and Fig. S1 G and H). We hypothesize that such free-energy changes are the result of interactions gained and lost. A52G adds an exocyclic amine on its sugar edge that likely serves as a hydrogen bond donor to both the N3 and the 2′-OH of A85 in the binding-pocket floor. These favorable contacts would form at the expense of the wild-type A-minor interaction while offsetting suboptimal base stacking against the binding pocket, consistent with the modestly favorable ΔΔG of −0.3 kcal⋅mol−1. By contrast, the A84G mutant adds a bulky N2 amine that likely forms a hydrogen bond with the 2′-OH of U17, albeit at the expense of the wild-type A-minor interaction. Beyond this compensatory interaction, the net unfavorable ΔΔG (i.e., 0.8 kcal⋅mol−1) could be the result of suboptimal π stacking with the pyrrole ring of the ligand. Overall, these findings have implications for the means by which ligand binding in the aptamer predisposes the expression platform to adopt gene regulatory conformations (discussed below).

Fig. S4.

Fig. S4.

Sequences of the preQ1-III riboswitch used for ITC, SHAPE, and smFRET. (A) The 74 env (environmental sequence) used for benchmarking ligand binding by a split sequence construct (Table S1 and Fig. S1 B and C). Strand 1 is black and strand 2 is red. (B) The wild-type Fpr riboswitch sequence used for SHAPE. The black sequences designated Fpr indicate wild-type 5′ and 3′ genomic extensions added between the riboswitch and the SHAPE cassette. The 5′ linker (green), spacer (pink), and reverse-transcription primer binding site (blue) are as described (41). All other sequences are color-coded as in Fig. 1B. The AUG start codon of the queT (COG4708) gene is highlighted (cyan). (C) smFRET split sequence (split seq) construct of the wild-type Fpr riboswitch that reports on helix P5 formation. P3 was extended to base pair with a 5′-biotinylated DNA oligonucleotide (maroon), allowing attachment to the quartz slide. The break in the P3 stem-loop was based on its poor phylogenetic conservation (23) and the feasibility of using a split seq construct was validated by ITC (Table S1 and Fig. S1B). (Inset) DNA sequence of an anti-P5, 11-mer oligonucleotide used in control experiments to block intramolecular helix P5 formation.

SHAPE Reactivity Changes Are Confined to the Core of the PreQ1-III Aptamer.

To explore how preQ1 binding influences RNA backbone flexibility in solution, we performed SHAPE analysis on the wild-type Fpr preQ1-III riboswitch in the context of a sequencing cassette (Fig. S4B). The addition of preQ1 to the riboswitch reduced reactivity at several positions, including P1, the U-rich region of P2, J3-4, and positions 84 and 86 (Fig. 4 A and B). Differential SHAPE-reactivity analysis showed strong P1 and P2 modulation (Fig. 4C), consistent with the crystal structure in which preQ1 mediates coaxial stacking between these helices (Figs. 1C and 2A). Nucleotides that contact preQ1 in the three-way junction also showed modulation, including C7 of J1-2, which recognizes the effector, and U8 of the major-groove triplex located in the floor of the binding pocket (Fig. 2A); U17 of J2-1, which directly recognizes the preQ1 edge (Fig. 2B); A52 of J3-4, which contributes an inclined A-minor interaction to the binding pocket on one face, and base stacking upon A53 with the other (Fig. 2 A and B); and A84 of J4-2, which contributes a second inclined A-minor interaction that directly abuts preQ1 (Fig. 2 A and B). Structural mapping of the differential SHAPE reactivity revealed that most changes occur within the three-way helical junction that composes the effector-binding site (Fig. 4D), suggesting that preQ1 reduces core backbone flexibility while promoting the HLout-type pseudoknot fold. By contrast, P3 and P4 are largely unaffected by preQ1, implying that they are prefolded. Perhaps the most surprising observation was the apparent lack of preQ1-dependent modulation within the anti-RBS and RBS sequences (i.e., helix P5; Fig. 4 A and C). This result prompted us to explore the feasibility of P5 helix formation by use of computational approaches.

Fig. 4.

Fig. 4.

Representative ligand dependence of 2′-OH chemical modification for the wild-type preQ1-III riboswitch. (A) Electrophoretic SHAPE analysis conducted in the absence and presence of preQ1 using the chemical modification reagent NAI; DMSO represents a control without NAI; U and G indicate reference nucleotide sequences. P1(s2) represents the 3′-most strand of helix P1; anti-RBS represents the P4 loop predicted to pair within helix P5; (−)preQ1 indicates no ligand and added NAI; (+)preQ1 indicates 100 μM ligand and added NAI. (B) High-resolution analysis of the 5′-riboswitch sequence similar to A, but emphasizing changes in P1 and P2 in the absence and presence of ligand. (C) Differential SHAPE reactivity as a function of nucleotide position. Reactivity is shown as a heat map; dark blue indicates little or no change; red indicates large differences between ligand bound and free states. (D) The crystal structure of the preQ1-III riboswitch (Fig. 1C) showing the spatial distribution of differential SHAPE reactivity using the heat map from C.

Computational Modeling Demonstrates the Structural Feasibility of RBS Sequestration.

The preQ1-I and preQ1-II riboswitches fold as pseudoknots that partially or fully integrate their expression platforms into the aptamer core (Fig. S2 B and C), features commonly observed in riboswitches that adopt H- and HLout-type pseudoknot architectures (7). By contrast, the preQ1-III riboswitch does not incorporate its expression platform into the aptamer, which folds as an HLout-type pseudoknot that is extended significantly in its “L3 loop” due to the inclusion of helix P3 (Fig. S2A). The most parsimonious pathway to achieve translational regulation by the preQ1-III riboswitch entails ligand-dependent sequestration of the RBS via formation of the P5 helix in the expression platform located distally from the aptamer domain. Although we identified a 3′ helix involving the RBS, its mode of burial in the crystal structure involves two molecules (Fig. 1B and Fig. S3 D and E), resulting in a base-pairing pattern inconsistent with bioinformatic analysis (23). Therefore, we used a computational approach to test the feasibility of producing an intramolecular P5 helix based on the crystal structure. Our results demonstrate that a “gene-off” conformation is readily attainable through burial of the RBS within helix P5, which forms the second stem of a partially nested H-type pseudoknot that encompasses the expression platform (Fig. 5A and Fig. S5A). Although the preQ1-III riboswitch model retains an intact HLout-type pseudoknot aptamer bound to preQ1, formation of helix P5 necessitates acute reorientation of helix P4 toward P2 (Fig. S5 B and C). Nevertheless, the model still accounts for the observed ITC and SHAPE measurements (Figs. 2B and 4D). Inspection of the 7-bp helix of P5 reveals three RBS nucleotides engage in canonical or wobble base-pair interactions, whereas the last two bases stack upon helix P5 (Fig. 5B). The model also concurs with bioinformatic sequence results that show conservation of P5 bases, but poor conservation of flanking bases in unpaired regions (23) (Fig. 5B, Inset). Although the model of the ligand-bound preQ1-III riboswitch shows considerable conformational flexibility during unrestrained MD simulations spanning 8 μs, P5 atoms showed little positional variation, supporting the stability of this helix on a microsecond timescale (Fig. S5 D and E).

Fig. 5.

Fig. 5.

Model of the preQ1-III riboswitch showing intramolecular base pairing of the RBS in helix P5. (A) Cartoon diagram of a representative all-atom computational model demonstrating the feasibility of loop P4 engagement in an H-type pseudoknot that sequesters a portion of the RBS within helix P5, consistent with a “gene off” conformation. (B) Close-up view of P5 showing explicit base pairs between the anti-RBS of the P4 loop and the 3′ RBS, representing the “docked” state. The view is rotated −90° about the z axis, and +45° about the x axis relative to A. (Inset) The model accounts for the proposed P5 secondary structure from bioinformatic analysis (23). Base-paired nucleotides of P5 are >93% conserved. Unpaired base 71 of J4-5 is present in only 75% of sequences as any base, and unpaired nucleotides 91 and 92 of J2-5 indicate a 75% preference for purine followed by any base in 95% of sequences.

Fig. S5.

Fig. S5.

Pseudoknot classification of the Fpr preQ1-III riboswitch expression platform model, and interhelical orientation of the crystal structure vs. a representative model with accompanying molecular dynamics trajectories. (A) The preQ1-III riboswitch model folds as a 5′ HLout-type pseudoknot (black) as described in Fig. S2A, but also exhibits a partially nested 3′ H-type pseudoknot (red) in which L1 = 0, allowing coaxial stacking of S1 and S2; the RBS at the 3′ terminus is highlighted (yellow). (B) Crystal structure of the preQ1-III riboswitch from Fig. 1C. The angle between P2—J4-2—P4 (yellow cone) is calculated as 61° based on the phosphorus atoms at C90, A84, and G63. (C) Representative model of the preQ1-III riboswitch after 2 μs of MD. The model is bound to preQ1 and maintains the HLout-type pseudoknot as observed in the crystal structure (Fig. 1 B and C); however, the model indicates P4 bending to an angle of 27° (yellow cone) to form P5. (D) Mass-weighted rmsd of all heavy atoms as a function of molecular dynamics simulation time for the model. Atoms for the P3 loop were excluded from the calculation. (E) Mass-weighted rmsd of atoms in P5 as function of simulation time based on the trajectories in D. P5 is defined by nucleotides 64–70 and 93–99 (Fig. 5B), and includes the RBS from position 97–101. (F) Intramolecular distance between atom C5 of U77 in helix P4 and atom O3′ of G101 in the RBS plotted as a function of simulation time. (G) Histogram distribution analysis showing the probability of encountering various U77–G101 distances, denoted (r), plotted for the atom pair in F. The distance of each peak is labeled. Analysis of trajectories was performed by Ptraj and Cpptraj from AmberTools (67).

Single-Molecule FRET Supports Dynamic RBS Sequestration upon preQ1 Binding.

To understand how ligand binding promotes RBS sequestration, we conducted smFRET analysis on a preQ1-III riboswitch construct harboring fluorophores that report on helix P5 formation (Fig. 6A and Fig. S4C). In buffer containing Mg2+ at a near-physiological concentration, ∼90% of riboswitches showed single-step photobleaching, consistent with the majority of molecules being monomeric under the low-concentration conditions of smFRET (Fig. 6B and Fig. S6 A–C). Importantly, the monomeric state is compatible with expectations for folding and gene regulation in an intracellular environment, which is reflected by our computational model (Fig. 5). The FRET histogram of the monomeric population in the absence of preQ1 showed a two-state distribution with a major (92%) ∼0.55 mid-FRET state, and a minor (8%) ∼0.89 high-FRET state (Fig. 6C and Fig. S7 AC). Under these conditions, a large fraction of the smFRET traces remained static in the mid-FRET state before photobleaching, but a smaller fraction was dynamic with multiple transitions between the two states (Fig. 6B, Top, and Fig. S6A). In a transition occupancy density plot (TODP), ∼32% of all molecules showed dynamics (Fig. 6D, Top). This analysis demonstrates that the preQ1-III riboswitch samples compactly folded P5 conformations in the absence of ligand, similar to preQ1-I and other riboswitch classes (11, 35). As little as 25 nM preQ1 increased the fraction of dynamic traces to ∼61% with a further shift to ∼69% at saturating 1 µM preQ1 (Fig. 6 B and D and Fig. S6 B and C). Consistent with the small fraction of molecules occupying the transient high-FRET state at any given time, the addition of more ligand led to only a modestly larger contribution of the high-FRET state to the population histogram (14%; Fig. 6C). Though small, this increase in the high-FRET state was consistently reproducible in multiple experiments (Fig. S7 A–C) and is supported by difference histogram analyses, which show decreases in the mid-FRET state and concomitant increases in the high-FRET population with added preQ1 (Fig. S7 D–F).

Fig. 6.

Fig. 6.

smFRET analysis of the preQ1-III riboswitch revealing the ligand dependence of dynamic RBS sequestration via P5 helix formation. (A) Schematic of the prism-based TIRF microscopy setup used to probe docking of helix P5 of the preQ1-III riboswitch by smFRET. Position U77 is labeled with Cy5 (red star); the 3′ terminus is labeled with Dy547 (green star). The mid-FRET distance of ∼55 Å corresponds to the length of the flexible self-avoiding polymer extending from position A91 to G101 (i.e., ∼26.0 Å) (54) added to the C90–U77 distance from the computational model (Fig. 5). In this conformation, helix P5 is not formed or undocked. The high-FRET state is consistent with the ∼38 Å distance between U77 and G101, observed in the preponderance of riboswitch models (Fig. S5 F and G); in this conformation, helix P5 is formed as a double-stranded RNA duplex or docked. As a basis for comparison, the intramolecular U77–G101 distance in the crystal structure is 66 Å. (B) Representative smFRET traces for each condition in the presence of no preQ1 (Top), 25 nM preQ1 (Middle), and 1 μM preQ1 (Bottom). Green, Dy547 intensity; red, Cy5 intensity; black, FRET efficiency; cyan, hidden Markov model fit. (C) FRET efficiency histograms of the preQ1-III riboswitch under the ligand concentrations in B. N indicates the number of molecules included in each histogram. Percentages in blue correspond to the high-FRET population. The mean FRET values are shown as fractional numbers in red and blue. (D) TODPs depicting heat-map contours corresponding to static, on-diagonal molecules and dynamic, off-diagonal molecules; here the fraction of static and dynamic molecules is shown for each condition in B. The percentage of dynamic molecules, represented by off-diagonal contours (dashed boxes), is indicated in gold.

Fig. S6.

Fig. S6.

Representative smFRET trajectories and exponential fits to extract life times (τ) for the docked and undocked states in the absence or presence of preQ1. (A) Trajectories in the absence of preQ1 in 1× smFRET buffer containing 1 mM Mg2+. (B) Trajectories in 25 nM preQ1 under conditions in A. (C) Trajectories in 1 μM preQ1 under conditions in A. Here and elsewhere, arrows indicate single-step photobleaching events of a fluorophore that results in loss of measureable FRET, and is indicative of a single intramolecular FRET pair. (D–F) Exponential fits to extract dwell times under ligand conditions in A–C. The smFRET construct used here and elsewhere is described in Fig. S4C.

Fig. S7.

Fig. S7.

Representative smFRET histograms recorded in the absence or presence of ligand in buffer containing Mg2+. Combined data are presented in Fig. 6. (A–C) Three independent experiments conducted in 1× smFRET buffer with 1 mM Mg2+ and various amounts of ligand as indicated. Red and blue peaks correspond to the mid- and high-FRET states representing the respective undocked and docked P5 conformations of Fig. 6A. The percentage of the high-FRET population in each condition is shown in blue text. (D–F) Difference histograms between the minus (−)preQ1 vs. 1 µM preQ1 conditions for each experiment. These plots demonstrate the small, but reproducible, differences in the FRET histograms upon addition of preQ1.

We then examined the effect of blocking P5 formation in the context of the wild-type Fpr preQ1-III riboswitch using an 11-nt DNA strand complementary to the riboswitch 3′ terminus (Fig. S4C, Inset, and SI Methods). This anti-P5 competitor resulted in complete loss of the high-FRET state and rendered almost all molecules static in a ∼0.4 mid-FRET state, both in the absence and presence of 1 µM preQ1 (Fig. S8 A–F). This finding further establishes that the high-FRET state corresponds to the P5 docked conformation wherein the RBS is sequestered. The lower mid-FRET value of ∼0.4 compared with the ∼0.55 value in the absence of DNA oligonucleotide suggests a small increase in separation between the fluorophores, as expected for a more rigid RNA–DNA duplex. Furthermore, addition of a small molecule known not to bind the preQ1-III riboswitch (i.e., isoxanthopterin (IXP) or 2-aminpurine (2AP); Fig. S1 I and J and SI Methods) revealed little increase in either the high-FRET state or the fraction of dynamic molecules, by contrast to preQ1 (Fig. S8 G–P), thereby demonstrating a highly specific response that occurs only with the cognate ligand.

Fig. S8.

Fig. S8.

smFRET control experiments for an anti-P5 DNA oligonucleotide and nonbinding ligands. (A) FRET histogram in the absence of preQ1 and the presence of 10 µM anti-P5 DNA oligonucleotide (Fig. S4C, Inset). (B) TODP for the experiment in A. (C) FRET histogram in the presence of 1 µM preQ1 and 10 µM anti-P5 DNA oligonucleotide. (D) TODP for the experiment in C. (E) Comparison of the histograms for the experiments in A (black) and C (red), as well as in the absence of the anti-P5 DNA oligonucleotide (gray), demonstrating a clear decrease in FRET in the presence of DNA. (F) Representative trace for the experiments in A and C, showing a typical static ∼0.4 mid-FRET state. (G–J) smFRET histograms under conditions of no ligand (G), 1 µM IXP (H), 1 µM 2AP (I), and 1 µM preQ1 (J). (K and L) Comparative and difference FRET histograms for the experiments in G–J, indicating the compaction and increase in high-FRET population specific to preQ1. (MP) TODPs for the corresponding experiments to the left in G–J, showing a significant increase in the fraction of dynamic molecules only in the presence of the cognate preQ1 ligand. (Q) Exemplary trace showing both dynamic and static behavior in the absence of ligand. (R) smFRET trace showing switching from the static to the dynamic regime upon addition of 1 µM preQ1 at ∼50 s as indicated. After preQ1 addition at ∼50 s, the molecule was incubated in the dark for 2 min, as indicated by the x-axis break, before commencing imaging. All experiments were performed in the presence of 1 mM Mg2+.

At the molecular level, the mean values of 0.55 and 0.89 for the mid- and high-FRET states correspond to distances of ∼52 and ∼38 Å, respectively. The mid-FRET state is consistent with the distance of ∼55 Å expected for an undocked P5 helix in which the RBS is solvent-exposed and flexible (Fig. 6A). The mean FRET value of this undocked state increased from 0.55 to 0.62 upon preQ1 addition (Fig. 6C), signifying a small compaction in the presence of ligand. The high-FRET state agrees well with distances observed for the preQ1-III riboswitch model in which P5 is docked (Fig. 5); specifically, the U77 to G101 distance that approximates the FRET pair was observed to be bimodal over 8 μs of MD simulations with maxima at ∼37 and ∼40 Å (Fig. S5 F and G). We also noted that in the absence of ligand, most traces displayed either static or dynamic behavior and switched rarely (<1%) between the two regimes (Fig. S8Q), which suggests that the two species interconvert slowly during our observation window (∼5 min) before photobleaching. However, individual molecules were observed to switch in situ from the static to the dynamic regime upon preQ1 addition (Fig. S8R), suggesting that ligand accelerates the transition into the dynamic, “active” conformation while the kinetics of dynamic molecules appeared unchanged. In the latter regard, the dynamic smFRET traces showed homogeneous kinetics that allowed us to calculate the rate constants of docking (kdock = 0.59 ± 0.03 s−1) and undocking (kundock = 1.10 ± 0.06 s−1) in the absence of preQ1. Notably, the rate constants were not affected substantially by addition of 25 nM or 1 µM preQ1 (Table 2). These relatively fast rate constants, and the diminutive size of the high-FRET population at equilibrium, provide a plausible explanation for the inability to observe preQ1-dependent formation of the P5 helix by SHAPE (Fig. 4).

Table 2.

PreQ1-III riboswitch P5 kinetics based on smFRET

Conditions kdock, s−1 kundock, s−1
Mg2+, mM PreQ1, nM Fast Slow Weighted mean Fast Slow Weighted mean
1.0* None n/a n/a 0.59 ± 0.03 n/a n/a 1.10 ± 0.06
1.0 25 n/a n/a 0.60 ± 0.01 n/a n/a 1.13 ± 0.06
1.0 1,000 n/a n/a 0.55 ± 0.01 n/a n/a 1.08 ± 0.03
None None 0.38 ± 0.01 0.05 ± 0.001 0.09 0.79 ± 0.01 0.12 ± 0.001 0.27
None 25 0.50 ± 0.01 0.06 ± 0.001 0.16 0.92 ± 0.02 0.12 ± 0.002 0.23
*

The errors reported for the kinetics in 1.0 mM Mg2+ are SDs from three independent experiments.

n/a, not applicable, because the rate was fit with a single exponential.

For conditions with no Mg2+, the SEs are derived from the quality of fits to a double-exponential function.

ITC analysis indicated that preQ1 binds the class III riboswitch in the absence of Mg2+ (Table S1), a result that is corroborated by smFRET analysis in which Mg2+-free experiments produced histograms similar to those in the presence of Mg2+ (Fig. S9A). However, the absence of Mg2+ resulted in heterogeneous kinetics wherein the weighted-mean value of kdock increased, and kundock was practically unchanged upon preQ1 addition (Table 2). These results suggest that the preQ1-III riboswitch transiently samples a docked P5 conformation even in the absence of both Mg2+ and preQ1 (Fig. S9 B and C). Notably, even though the addition of preQ1 affects P5 docking in the absence of Mg2+, the fraction of dynamically docking P5 helices is unaltered (Fig. S9D). The lack of preQ1 dependence and absence of Mg2+ diminish the likelihood that such dynamics are operative in gene control. Instead, our regulatory model is best framed within the context of near-physiological Mg2+ concentrations wherein the addition of preQ1 does not alter docking and undocking rates (Table 2) but enhances the fraction of molecules competent to undergo dynamic P5 docking (Fig. 6D), thus leading to RBS sequestration within the 3′-terminal H-type pseudoknot (Fig. 5B).

Fig. S9.

Fig. S9.

smFRET histograms, trajectories, and TODPs for smFRET experiments recorded in the absence or presence of ligand in buffer without Mg2+. (A) smFRET histograms compiled from trajectories under various preQ1 conditions. Histograms are shown for the mid-FRET population (red) and high-FRET population (blue); percentage values for the high-FRET state are in blue text. (B) Representative trajectories in the absence of preQ1. (C) Representative trajectories in 25 nM preQ1. (D) Representative TODPs for samples recorded under ligand conditions in B (Upper) and C (Lower).

SI Methods

Riboswitch ITC Control Experiments.

Control experiments with nonbinding compounds used IXP (Carbosynth Ltd.) and 2AP (TCI America). For control experiments, 33 μM IXP or 150 μM 2AP was titrated into 3.2 μM wild-type Fpr. Representative thermograms and chemical structures are provided (Fig. S1 I and J).

Riboswitch Crystallization Solutions.

The well solutions of hanging-drop experiments were composed of the following conditions. To prepare a “native” crystal of the PM construct with a G•U pair (53) (Fig. 1B, Inset), 74.5% Tacsimate (pH 7.0; Hampton Research), was combined with 0.050 M Mops (pH 7.0), 0.020 M Co(NH3)6Cl3, and 0.001 M spermine•HCl. The well solution used to prepare a heavy atom-derivatized PM crystal contained 1.9 M Na–malonate (pH 7.0; Hampton Research), 0.20 M CsCl, 0.050 M Na–Mops (pH 7.0), 0.050 M Mg(C2H3O2)2, and 0.001 M spermine•HCl. Crystals of the wild-type sequence (Fig. 1B) used for high-resolution refinement were prepared from a well solution of 85% Tacsimate (pH 7.0), 0.010 M Mg(C2H3O2)2, 0.006 M Co(NH3)6Cl3, and 0.001 M spermine•HCl.

Phase Determination, Refinement, and Analysis.

The phase problem was solved by SIRAS to 3.0 Å resolution. To prepare a heavy-atom derivative, a crystal of the PM construct was cocrystallized with Cs+, and yielded a dataset with measurable anomalous diffraction to 4.45 Å using Phenix.xtriage (51). A PM crystal with no Cs+ was used as a native dataset. Phenix.AutoSol (51) located seven Cs+ ions producing an initial mean figure of merit of 0.37 to 3.0 Å resolution; density modification yielded maps with discernible RNA features (Fig. S3B). Phenix.AutoBuild (51) was used to trace the backbone, followed by iterative use of Phenix.refine (51) interspersed with manual building in Coot (55). The resolution of the structure was extended to 2.75 Å resolution using data from an isomorphous crystal with the wild-type Fpr sequence. The structure converged on Rcryst/Rwork/Rfree values of 21.4/21.2/22.8% with acceptable geometry, and a clash score of 1.24 (Table 1). The quality of the refined structure is indicated by the clear electron density for all nucleotides, except a break at positions 34 and 35 within the P3 loop (Fig. S3C). PreQ1 is visible in omit and unbiased electron density maps that define its placement in the structure (Fig. 2B and Fig. S3A); the ligand-binding pocket is free from crystallographic contacts (Fig. S3F).

Riboswitch MD Simulations.

All simulations were conducted using Amber14 with the ff10 force field, which is unchanged for nucleic acids in ff12SB (5658); a modified force-field parameter was used for improper dihedrals for the exocyclic amine in G•A imino pairs (59). The model was solvated in an isometric box using TIP3P (60). For charge neutralization, 100 Na+ ions were added, along with 150 Na+ and 150 Cl ions to generate 0.1 M NaCl (61, 62). The system comprises 139,811 atoms in a 125 × 125 × 125 Å octahedral box. To produce preQ1, charge and force-field parameters were generated. Hydrogen was added to the methylamine using reduce in AmberTools (63). The RED RESP server (6466) was used to optimize geometry and to generate atomic point charges at the HF/6–31G* quantum calculation level. Other force-field parameters were obtained using Amber antechamber (67). The model with P5 pairing was subjected to 500 ns of unrestrained MD, and then used as the starting coordinates for four additional ligand-bound MD simulations of 2 μs each; trajectory rmsd values and P4–P5 distances are provided (Fig. S5). Coordinates from Fig. 5 may be obtained from the corresponding author upon request.

SmFRET Analysis.

The anti-P5 11-nt DNA oligonucleotide (Fig. S4C, Inset) was synthesized chemically followed by desalting (Sigma-Aldrich); the dry pellet was dissolved in polished water as a 0.10 M stock. Experiments that used the anti-P5 DNA strand were examined as described in Methods. Briefly, the surface-bound RNA was incubated with smFRET buffer containing the OSS with or without preQ1 in the presence of 10 μM anti-P5 DNA at room temperature for 15 min before imaging at 16 fps. The control experiments with IXP and 2AP were done on the same quartz slide starting with no ligand, followed by addition of 1 μM each of IXP, 2AP, and preQ1 in 1× smFRET buffer with OSS. Between different ligand titrations, the microfluidic channel was washed with the 1× buffer multiple times to remove the free ligand. For all experiments, specific smFRET traces were selected for further analysis provided that they met the following criteria: trace time >6 s; total intensity (donor + acceptor) >300 (arbitrary units); signal-to-noise ratio >5; and single-step photobleaching of Dy-547 and/or Cy5 (Figs. 6B and Figs. S6 A–C and S9 B and C). Dimers were identified and excluded from analysis when smFRET traces exhibited two-step photobleaching of Dy547 and/or Cy5. For each experimental condition, population histograms (Fig. 6C and Figs. S7 A–C, S8 A, C, and GJ, and S9A) were plotted by binning the first 100 frames from each of several hundred molecules. FRET histograms were fit with a sum of Gaussian functions to extract the means and areas of individual peaks using Origin 8.5 (MicroCal). To estimate the kinetics of conformational changes, the smFRET traces were idealized to a two-state model using a hidden Markov model-based segmental k-means algorithm as implemented in QuB (68). The cumulative distributions of dwell times in each FRET state were plotted and fitted with exponential functions to obtain the lifetimes in the undocked and docked states, thereby estimating kdock and kundock rate constants (Table 2 and Fig. S6 D–F). The idealized smFRET traces were used to create TODPs using MATLAB as described (69).

Discussion

Here we report the crystal structure of a preQ1-III riboswitch bound to its effector (Figs. 1C and 2), thereby establishing the fold of a new class of regulatory RNA. The riboswitch can be parsed structurally into an aptamer domain composed of an HLout-type pseudoknot that has co-opted major-groove base triples for ligand recognition (Fig. 3), and a downstream, partially embedded H-type pseudoknot that sequesters the RBS (Fig. 5). Such structural organization is uncommon among riboswitches (7, 19) and has not been investigated to an appreciable extent in terms of structure–function relationships (35). As such, we established a functional framework for the preQ1-III riboswitch that entails ligand-dependent folding in the presence of Mg2+ to promote a compact aptamer that is conducive to dynamic docking and undocking of the remotely positioned RBS (Fig. 6A). Frequent docking of the RBS would sequester the expression platform, leading to ligand-dependent queT gene control by translational attenuation. This paradigm differs from other riboswitches, such as preQ1-II and SAM-II, because these molecules integrate RBS sequences directly into their aptamer domains upon ligand binding (8, 10, 12, 16, 18). Consequently, RBS docking within these riboswitches is characterized by prolonged high-FRET dwell times in the presence of Mg2+ and ligand (>2.2 s and ∼3.5 s, respectively) with timescales limited most likely by fluorophore photobleaching (10, 16). By contrast, the preQ1-III riboswitch displays dwell times of ∼0.9 s for the RBS-docked state, and ∼1.8 s for the undocked state (Fig. S6 D–F). This dynamic character differentiates the preQ1-III riboswitch from other regulatory RNAs that appear to rely upon comparatively static conformational states to achieve RBS sequestration.

We then considered the molecular basis by which effector binding to the preQ1-III aptamer leads to a larger population of riboswitches that dynamically sequester the remote RBS. Our results indicated that preQ1 binding only marginally stabilizes P5 docking, which occurs entirely through an increasing fraction of molecules that dynamically access the high-FRET docked state, and is evident in our kinetic analysis wherein no substantive rate changes occurred in kdock (∼0.6 s−1) or kundock (∼1.1 s−1) under conditions containing Mg2+ and preQ1 vs. those with Mg2+ and no ligand (Table 2). These observations are consistent with a ligand-dependent aptamer conformation that reorients preformed helix P4 acutely relative to the P2–P1–P3 coaxial stack. Such positioning would predispose helix P5 to dock, thus completing the H-type pseudoknot with concomitant RBS burial. Our computational model demonstrates the feasibility and stability of this relatively compact fold (Fig. 5 and Fig. S5 D and E), which requires preQ1 binding for full efficacy (Fig. 6D and Fig. S8).

Coupling of preQ1 binding within the HLout-type pseudoknot aptamer to distal RBS sequestration within the H-type pseudoknot depends on inclined A-minor base A52 of J3-4 and base A84 of J4-2, which are 75% and 97% conserved (23). ITC confirmed that both adenines affect preQ1 binding (Fig. 2B and Table S1), although neither base hydrogen bonds directly to the ligand. SHAPE analysis revealed greater backbone stability of these nucleotides in the presence of preQ1, which is corroborated by the crystal structure (Fig. 4 C and D). Specifically, preQ1 engages in a T-shaped π-stacking interaction with A84, which simultaneously forms a cross-strand stacking interaction with A52 (Fig. 7A). Importantly, the stacking of A84 upon A52 abuts a network of continuously stacked bases in helix P4 that begins at A53 and culminates in the anti-RBS sequence (Fig. 7A). This stacking network is maintained in the computational model wherein helix P5 is docked by pairing of the anti-RBS and RBS sequences, which requires helix P4 repositioning (Fig. 7B). In this manner, preQ1 binding establishes a continuous stacking network that predisposes P4 to reorient acutely toward the P1–P2 coaxial stack, favoring P5 docking and RBS sequestration.

Fig. 7.

Fig. 7.

Stereo diagrams depicting inclined A-minor bases of the preQ1-II and preQ1-III riboswitches mediating stacking interactions between the ligand and a nearby helix. (A) The preQ1-III riboswitch crystal structure depicting nucleotides that compose the binding pocket and flank the ligand (rendered as transparent surfaces covering ball-and-stick models); helix P4 is drawn as a ribbon with nucleotides depicted as sticks. The pyrrole ring of preQ1 forms an edge-to-face interaction with A-minor base A84 that is integral to formation of the binding pocket. On its opposite face, A84 stacks upon A52, forming a cross-strand interaction. A52 also stacks against neighboring purine A53, establishing a continuous base stack through helix P4 that culminates in the anti-RBS loop. In this manner, preQ1 occupancy within the binding pocket influences the orientation of P4. The view is similar to Fig. 2B. (B) Representative computational model of the preQ1-III riboswitch bound to preQ1 as described in A. The inclined A-minor interactions of the crystal structure (Fig. 2B) are preserved in the model, and base stacking is still continuous from A84 to the anti-RBS, despite formation of the P5 helix that sequesters the RBS. (C) Analogous view of the preQ1-II riboswitch (PDB ID code 2MIY) (12) illustrating preQ1 packing against structurally homologous inclined A-minor bases A50 and A35. Like the preQ1-III riboswitch, these bases form a continuous stacking interaction that influences the conformation of helix P4. Here, the pocket floor contains the first base of the RBS (yellow) located directly beneath preQ1.

Although the broader role of inclined A-minor bases in the context of H- and HLout-type pseudoknots is to stabilize a 5′-terminal stem (7), the preQ1-II riboswitch provides a precedent for the use of such adenine bases in mediating base stacking between a ligand and a nearby orthogonal stem-loop (Fig. 7C). Specifically, preQ1 binding to the class II riboswitch alters P4 helical dynamics and its proximity to the orthogonally oriented aptamer domain (12, 16). Like the preQ1-III riboswitch, ITC analysis of preQ1-II A-minor adenines verified the importance of these bases in preQ1 binding, although larger ΔΔG values were observed upon mutagenesis indicative of greater losses in ligand binding (12). Nonetheless, there is notable structural homology between the inclined A-minor adenines of the preQ1-II and preQ1-III riboswitches (Fig. 7 A and B vs. Fig. 7C) that lends support for the mode by which preQ1 binding to the preQ1-III aptamer can influence the orientation of helix P4 in a manner that favors formation of distal helix P5 and concurrent RBS sequestration. Conversely, ligand deficiency in the preQ1-III aptamer domain destabilizes helices P1 and P2, resulting in increased flexibility of the inclined A-minor bases (Fig. 4). Thus, although a fraction of the riboswitch population can dynamically sequester the RBS in the absence of ligand, translational control by the preQ1-III riboswitch requires a folded aptamer and preQ1 binding for greatest efficacy (Fig. 6D and Fig. S8).

Overall, our results provide a molecular-level framework to understand how effector binding within the preQ1-III riboswitch aptamer influences the conformation of a distal expression platform. In this context, the dynamic character of the RBS is unusual compared with other riboswitches, and our work demonstrates how a nonintegrated expression platform can achieve ligand-dependent translational attenuation without burial in the aptamer core. This paradigm is likely applicable to other riboswitches, especially those with bipartite structural organization, thus expanding the known repertoire of translational attenuation strategies.

Methods

Riboswitch Production and Isothermal Titration Calorimetry.

Faecalibacterium prausnitzii (Fpr) preQ1-III riboswitches and mutants thereof (Fig. 1B and Table S1) were generated by in vitro transcription and purified by denaturing PAGE (36). The 74 env sequences (Fig. S4A) were produced by chemical synthesis (GE Life Sciences) and HPLC purified (37); preQ1 was prepared as described (18). Lyophilized RNA was suspended in a folding buffer comprising 0.050 M Na-Hepes (pH 7.0) containing 0.10 M NaCl. The Fpr RNA was heated to 65 °C for 5 min followed by addition of 0.006 M MgCl2 or 0.0005 M EDTA before slow cooling. The 74 env RNA was folded by heating each strand at 70 °C, mixing the strands, and incubating at 37 °C for 2 min before the addition of Mg2+. Samples were then incubated at 37 °C for 20 min followed by flash cooling on ice. ITC measurements were conducted using a VP-ITC calorimeter (MicroCal, Inc.) as described (38) in which the folding buffer above included 0.006 M MgCl2 or 0.0005 M EDTA to produce ITC buffer. Each sample (Fig. S1) was dialyzed at 4 °C overnight against 4 L of ITC buffer. RNA was diluted with dialysis buffer to 3.1–3.3 μM for wild-type Fpr, 3.2–7.8 μM for the A52G and A84G Fpr mutants, 10.5–15.7 μM for the C7U and U17C Fpr mutants, 2.4–3.6 μM for 74 env, and 1.8 μM for 74 env-s2Δ30–43. PreQ1 was dissolved in dialysis buffer at concentrations ∼10-fold higher than RNA. Thermograms were analyzed with Origin 7.0 (MicroCal) using a 1:1 binding model. Average thermodynamic parameters and representative thermograms with curve fits are provided (Table S1 and Fig. S1). See SI Methods for details of the IXP and 2AP control experiments.

Riboswitch Crystallization and X-ray Data Collection.

PreQ1-III riboswitch RNA (Fig. 1B) was dissolved to 0.16 mM in 0.010 M Na-cacodylate (pH 7.0). RNA was folded by heating to 65 °C for 3 min followed by addition of 0.006 M MgCl2 and 0.32 mM preQ1; subsequently, the RNA was heated to 65 °C for 5 min, followed by slow cooling and 0.2-μm filtration. Crystals were prepared by the hanging-drop vapor-diffusion method in which 1.6–2.0 μL of folded RNA was mixed with an equal volume of well solution, followed by equilibration over 1 mL of well solution at 20 °C. Crystals grew as hexagonal rods within 24 h and achieved a maximum size of 0.2 × 0.05 × 0.05 mm within a week. See SI Methods for crystallization solutions. All crystals were flash-frozen by washing in well solution supplemented with 0.32 mM preQ1, then plunging into N2(l). X-ray diffraction data for phasing were recorded at the Stanford Synchrotron Radiation Lightsource (SSRL) beamline 7-1. Phasing module (PM) data were reduced with HKL2000 software (39). High-resolution data were recorded at SSRL beamline 11-1 and reduced with XDS/XSCALE (40) (Table 1).

Phase Determination, Refinement, and Analysis.

Experimental phases were obtained by single isomorphous replacement with anomalous scattering (SIRAS) to 3.0 Å resolution. Subsequently, the resolution was extended to 2.75-Å resolution with refinement to reasonable Rfactors and geometry (Table 1). Details are available in SI Methods.

Chemical Modification by Selective 2′-Hydroxyl Acylation Analyzed by Primer Extension.

The ligand-dependent acylation of the Fpr preQ1-III riboswitch was probed by SHAPE (41) (Fig. 4 and Fig. S4B); nicotinic acid imidazole (NAI) was synthesized as described (42). Purified RNA from in vitro transcription (36) was heated in metal-free water for 2 min at 95 °C, then flash-cooled on ice. A 3× SHAPE buffer [0.333 M Hepes (pH 8.0), 0.02 M MgCl2, 0.333 M NaCl] was added and the RNA was equilibrated at 37 °C for 10 min. A total of 1 μL of preQ1 stock (1 M in 1× PBS) was added to the RNA. The RNA was incubated at 37 °C for 15 min. To this mixture, 1 μL of 10× NAI stock in DMSO (+), or DMSO alone (−) (Fig. 4 A and B), was added to a final concentration of 0.06 M. The NAI reaction proceeded for 15 min followed by one extraction with acid phenol:chloroform (pH 4.5 ± 0.2) and two with chloroform. RNA was precipitated with 40 μL of 3 M sodium acetate (pH 5.2) containing 1 μL of glycogen (20 μg μL−1). Pellets were washed twice with 70% ethanol and suspended in 10 μL RNase-free water. Extension using 32P-labeled primer and data analysis were as described (41, 42).

Riboswitch Modeling and MD Simulations.

To evaluate the feasibility of P5 base pairing, a steered MD simulation was performed starting from the Fpr crystal structure (Fig. 1C). The P4 loop (nucleotides 64–70) was moved toward nucleotides 93–99 using distance restraints with three force-constant steps applied over a total time of 10 ns. The equilibrium distance between the heavy atom of the hydrogen bond acceptor to the hydrogen atom of the donor was set to 2.5 Å. First, the distance restraint force constant was ramped from 0 to 5 kcal (mol × Å2)−1 in 100 ps, followed by an interval of constant force, and then a ramp from 5 to 0 kcal (mol × Å2)−1 in the last 100 ps. The restraints were harmonic to 15 Å, and then the potential became flat. Each hydrogen bond of a canonical base pair in P5 was restrained. A model was selected manually from 10 pulling simulations that exhibited features consistent with the “modeling restraints” derived from the crystal structure (Fig. 1C), ITC (Fig. 2B), SHAPE (Fig. 4C), as well as prior in-line probing and bioinformatic analyses (23). This model was then subjected to two-stage minimization. First, the riboswitch was fixed spatially with a restraint force of 500 kcal (mol × Å2)−1, and solvent and counterions were energy minimized for 5,000 steps. Next, solvent and RNA were minimized for 5,000 steps. Each minimization had 2,500 steepest descent steps, followed by 2,500 conjugate gradient steps. The final system was subjected to 100 ps of heating from 0 to 300 K in the canonical ensemble [i.e., the NVT ensemble comprising a constant number of particles (N), volume (V), and temperature (T)] by holding the RNA in space with a harmonic potential of 10 kcal (mol × Å2)−1. Finally, 100 ps of isothermal-isobaric ensemble [i.e., the NPT ensemble comprising a constant N, pressure (P), and T] simulation was performed to equilibrate at 300 K; a Langevin thermostat was used for temperature control with a collision frequency of 1,000 ps−1. The particle-mesh Ewald (43, 44) method was used to calculate long-range electrostatics with a 10-Å cutoff for the direct space sum. Bonds involving hydrogen were retrained by the program SHAKE (45). Additional details are provided in SI Methods.

Single-Molecule FRET Analysis.

The Fpr preQ1-III riboswitch was produced by chemical synthesis (GE Life Sciences) from two RNA strands (Fig. S4C). The feasibility of producing a functional split riboswitch was demonstrated by ITC analysis of the 74 env preQ1-III riboswitch, which yielded an apparent KD of 10.1 ± 2.5 nM (Table S1 and Figs. S1B and S4A), indicating high-affinity preQ1 binding. Extension of the 5′-RNA smFRET strand allowed hybridization to a biotinylated DNA tether (IDT, Inc.). The RNA strand harboring the RBS included 5-amino-allyl-U77 and Dy547 at the 3′ terminus. A Cy5 label (GE Healthcare) was added as described (46), and both RNA strands were PAGE-purified and desalted (36). To fold the RNA, 1 µM of each strand was combined and annealed at 70 °C for 3 min in 0.050 M Hepes–KOH (pH 7.0). KCl was added to a concentration of 0.1 M with additional heating at 70 °C for 2 min followed by 5-min incubation at 37 °C. The RNA was cooled to 23 °C for 10 min. smFRET experiments were performed using a prism-based total internal reflection fluorescence (TIRF) microscopy setup (Fig. 6A) (11, 47). Briefly, quartz slides containing microfluidic channels were coated with biotinylated BSA followed by streptavidin treatment. Unbound protein was washed away by 1× smFRET buffer [0.050 M Hepes–KOH (pH 7.0), 0.1 M KCl, with or without 0.001 M Mg2+]. Immobilization of 10–25 pM of folded riboswitch was achieved using the biotin–streptavidin interaction. Unbound molecules were washed away with 1× smFRET buffer. An oxygen scavenging system (OSS) containing 5 mM protocatechuic acid, 50 nM protocatechuate 3,4-dioxygenase, and 2 mM Trolox in smFRET buffer was used to prolong fluorophore longevity and reduce photoblinking (11). Molecules were imaged by an intensified-CCD camera (I-PentaMAX; Princeton Instruments) at a time resolution of ∼60 ms in the absence or presence of various preQ1 concentrations. Dy547 was excited directly using a 532-nm laser, and emission intensities from both Dy547 (donor, ID) and Cy5 (acceptor, IA) were recorded simultaneously, and used to calculate the FRET ratio as IA/(IA + ID) after background correction. The raw FRET movies were processed using IDL (Research Systems) to extract time traces of individual molecules, and analyzed further by custom MATLAB (MathWorks) scripts. See SI Methods for further details.

Supplementary Material

Acknowledgments

We thank J. Jenkins, S. Bellaousov, E. Salsi, D. Ermolenko, and C. Kielkopf for helpful analysis and discussion, and C. Brooks for editing assistance. This research was funded by NIH Grants GM076485 (to D.H.M.), GM062357 (to N.G.W.), and RR026501 and GM063162 (to J.E.W.). Portions of this work were conducted at SSRL, funded by NIH Grants GM103393 and RR001209, and the Department of Energy.

Footnotes

The authors declare no conflict of interest.

This article is a PNAS Direct Submission.

Data deposition: The atomic coordinates have been deposited in the Protein Data Bank, www.pdb.org (PDB ID code 4RZD).

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1503955112/-/DCSupplemental.

References

  • 1.Serganov A, Nudler E. A decade of riboswitches. Cell. 2013;152(1-2):17–24. doi: 10.1016/j.cell.2012.12.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Roth A, Breaker RR. The structural and functional diversity of metabolite-binding riboswitches. Annu Rev Biochem. 2009;78:305–334. doi: 10.1146/annurev.biochem.78.070507.135656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sudarsan N, Cohen-Chalamish S, Nakamura S, Emilsson GM, Breaker RR. Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine. Chem Biol. 2005;12(12):1325–1335. doi: 10.1016/j.chembiol.2005.10.007. [DOI] [PubMed] [Google Scholar]
  • 4.Blount KF, Wang JX, Lim J, Sudarsan N, Breaker RR. Antibacterial lysine analogs that target lysine riboswitches. Nat Chem Biol. 2007;3(1):44–49. doi: 10.1038/nchembio842. [DOI] [PubMed] [Google Scholar]
  • 5.Lee ER, Blount KF, Breaker RR. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA Biol. 2009;6(2):187–194. doi: 10.4161/rna.6.2.7727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Breaker RR. Riboswitches and the RNA world. Cold Spring Harb Perspect Biol. 2012;4(2):a003566. doi: 10.1101/cshperspect.a003566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Peselis A, Serganov A. Structure and function of pseudoknots involved in gene expression control. Wiley Interdiscip Rev RNA. 2014;5(6):803–822. doi: 10.1002/wrna.1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gilbert SD, Rambo RP, Van Tyne D, Batey RT. Structure of the SAM-II riboswitch bound to S-adenosylmethionine. Nat Struct Mol Biol. 2008;15(2):177–182. doi: 10.1038/nsmb.1371. [DOI] [PubMed] [Google Scholar]
  • 9.Spitale RC, Torelli AT, Krucinska J, Bandarian V, Wedekind JE. The structural basis for recognition of the PreQ0 metabolite by an unusually small riboswitch aptamer domain. J Biol Chem. 2009;284(17):11012–11016. doi: 10.1074/jbc.C900024200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Haller A, Rieder U, Aigner M, Blanchard SC, Micura R. Conformational capture of the SAM-II riboswitch. Nat Chem Biol. 2011;7(6):393–400. doi: 10.1038/nchembio.562. [DOI] [PubMed] [Google Scholar]
  • 11.Suddala KC, et al. Single transcriptional and translational preQ1 riboswitches adopt similar pre-folded ensembles that follow distinct folding pathways into the same ligand-bound structure. Nucleic Acids Res. 2013;41(22):10462–10475. doi: 10.1093/nar/gkt798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kang M, Eichhorn CD, Feigon J. Structural determinants for ligand capture by a class II preQ1 riboswitch. Proc Natl Acad Sci USA. 2014;111(6):E663–E671. doi: 10.1073/pnas.1400126111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Jenkins JL, Krucinska J, McCarty RM, Bandarian V, Wedekind JE. Comparison of a preQ1 riboswitch aptamer in metabolite-bound and free states with implications for gene regulation. J Biol Chem. 2011;286(28):24626–24637. doi: 10.1074/jbc.M111.230375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kang M, Peterson R, Feigon J. Structural Insights into riboswitch control of the biosynthesis of queuosine, a modified nucleotide found in the anticodon of tRNA. Mol Cell. 2009;33(6):784–790. doi: 10.1016/j.molcel.2009.02.019. [DOI] [PubMed] [Google Scholar]
  • 15.Klein DJ, Edwards TE, Ferré-D’Amaré AR. Cocrystal structure of a class I preQ1 riboswitch reveals a pseudoknot recognizing an essential hypermodified nucleobase. Nat Struct Mol Biol. 2009;16(3):343–344. doi: 10.1038/nsmb.1563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Soulière MF, et al. Tuning a riboswitch response through structural extension of a pseudoknot. Proc Natl Acad Sci USA. 2013;110(35):E3256–E3264. doi: 10.1073/pnas.1304585110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ren A, Rajashankar KR, Patel DJ. Fluoride ion encapsulation by Mg2+ ions and phosphates in a fluoride riboswitch. Nature. 2012;486(7401):85–89. doi: 10.1038/nature11152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Liberman JA, Salim M, Krucinska J, Wedekind JE. Structure of a class II preQ1 riboswitch reveals ligand recognition by a new fold. Nat Chem Biol. 2013;9(6):353–355. doi: 10.1038/nchembio.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Trausch JJ, et al. Structural basis for diversity in the SAM clan of riboswitches. Proc Natl Acad Sci USA. 2014;111(18):6624–6629. doi: 10.1073/pnas.1312918111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gao A, Serganov A. Structural insights into recognition of c-di-AMP by the ydaO riboswitch. Nat Chem Biol. 2014;10(9):787–792. doi: 10.1038/nchembio.1607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jones CP, Ferré-D’Amaré AR. Crystal structure of a c-di-AMP riboswitch reveals an internally pseudo-dimeric RNA. EMBO J. 2014;33(22):2692–2703. doi: 10.15252/embj.201489209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ren A, Patel DJ. c-di-AMP binds the ydaO riboswitch in two pseudo-symmetry-related pockets. Nat Chem Biol. 2014;10(9):780–786. doi: 10.1038/nchembio.1606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.McCown PJ, Liang JJ, Weinberg Z, Breaker RR. Structural, functional, and taxonomic diversity of three preQ1 riboswitch classes. Chem Biol. 2014;21(7):880–889. doi: 10.1016/j.chembiol.2014.05.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Noguchi S, Nishimura Y, Hirota Y, Nishimura S. Isolation and characterization of an Escherichia coli mutant lacking tRNA-guanine transglycosylase. Function and biosynthesis of queuosine in tRNA. J Biol Chem. 1982;257(11):6544–6550. [PubMed] [Google Scholar]
  • 25.Harada F, Nishimura S. Possible anticodon sequences of tRNA His, tRNA Asm, and tRNA Asp from Escherichia coli B. Universal presence of nucleoside Q in the first postion of the anticondons of these transfer ribonucleic acids. Biochemistry. 1972;11(2):301–308. doi: 10.1021/bi00752a024. [DOI] [PubMed] [Google Scholar]
  • 26.Bienz M, Kubli E. Wild-type transfer-RNA GTyr reads the TMV RNA stop codon, but Q-base-modified transfer-RNA GTyr does not. Nature. 1981;294(5837):188–190. doi: 10.1038/294188a0. [DOI] [PubMed] [Google Scholar]
  • 27.Meier F, Suter B, Grosjean H, Keith G, Kubli E. Queuosine modification of the wobble base in tRNAHis influences ‘in vivo’ decoding properties. EMBO J. 1985;4(3):823–827. doi: 10.1002/j.1460-2075.1985.tb03704.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Urbonavičius J, Qian Q, Durand JM, Hagervall TG, Björk GR. Improvement of reading frame maintenance is a common function for several tRNA modifications. EMBO J. 2001;20(17):4863–4873. doi: 10.1093/emboj/20.17.4863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Katze JR, Basile B, McCloskey JA. Queuine, a modified base incorporated posttranscriptionally into eukaryotic transfer RNA: Wide distribution in nature. Science. 1982;216(4541):55–56. doi: 10.1126/science.7063869. [DOI] [PubMed] [Google Scholar]
  • 30.Rakovich T, et al. Queuosine deficiency in eukaryotes compromises tyrosine production through increased tetrahydrobiopterin oxidation. J Biol Chem. 2011;286(22):19354–19363. doi: 10.1074/jbc.M111.219576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Durand JM, et al. vacC, a virulence-associated chromosomal locus of Shigella flexneri, is homologous to tgt, a gene encoding tRNA-guanine transglycosylase (Tgt) of Escherichia coli K-12. J Bacteriol. 1994;176(15):4627–4634. doi: 10.1128/jb.176.15.4627-4634.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Meyer MM, Roth A, Chervin SM, Garcia GA, Breaker RR. Confirmation of a second natural preQ1 aptamer class in Streptococcaceae bacteria. RNA. 2008;14(4):685–695. doi: 10.1261/rna.937308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Roth A, et al. A riboswitch selective for the queuosine precursor preQ1 contains an unusually small aptamer domain. Nat Struct Mol Biol. 2007;14(4):308–317. doi: 10.1038/nsmb1224. [DOI] [PubMed] [Google Scholar]
  • 34.Smith KD, Shanahan CA, Moore EL, Simon AC, Strobel SA. Structural basis of differential ligand recognition by two classes of bis-(3′-5′)-cyclic dimeric guanosine monophosphate-binding riboswitches. Proc Natl Acad Sci USA. 2011;108(19):7757–7762. doi: 10.1073/pnas.1018857108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Savinov A, Perez CF, Block SM. Single-molecule studies of riboswitch folding. Biochim Biophys Acta. 2014;1839(10):1030–1045. doi: 10.1016/j.bbagrm.2014.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lippa GM, et al. Crystallographic analysis of small ribozymes and riboswitches. Methods Mol Biol. 2012;848:159–184. doi: 10.1007/978-1-61779-545-9_11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wedekind JE, McKay DB. Purification, crystallization, and X-ray diffraction analysis of small ribozymes. Methods Enzymol. 2000;317:149–168. doi: 10.1016/s0076-6879(00)17013-2. [DOI] [PubMed] [Google Scholar]
  • 38.Liberman JA, Bogue JT, Jenkins JL, Salim M, Wedekind JE. ITC analysis of ligand binding to preQ₁ riboswitches. Methods Enzymol. 2014;549:435–450. doi: 10.1016/B978-0-12-801122-5.00018-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307–326. doi: 10.1016/S0076-6879(97)76066-X. [DOI] [PubMed] [Google Scholar]
  • 40.Kabsch W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 2):133–144. doi: 10.1107/S0907444909047374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Wilkinson KA, Merino EJ, Weeks KM. Selective 2′-hydroxyl acylation analyzed by primer extension (SHAPE): Quantitative RNA structure analysis at single nucleotide resolution. Nat Protoc. 2006;1(3):1610–1616. doi: 10.1038/nprot.2006.249. [DOI] [PubMed] [Google Scholar]
  • 42.Spitale RC, et al. RNA SHAPE analysis in living cells. Nat Chem Biol. 2013;9(1):18–20. doi: 10.1038/nchembio.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Toukmaji A, Sagui C, Board J, Darden T. Efficient particle-mesh Ewald based approach to fixed and induced dipolar interactions. J Chem Phys. 2000;113:10913–10927. [Google Scholar]
  • 44.Sagui C, Pedersen LG, Darden TA. Towards an accurate representation of electrostatics in classical force fields: Efficient implementation of multipolar interactions in biomolecular simulations. J Chem Phys. 2004;120(1):73–87. doi: 10.1063/1.1630791. [DOI] [PubMed] [Google Scholar]
  • 45.Miyamoto S, Kollman PA. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem. 1992;13:952–962. [Google Scholar]
  • 46.Akiyama BM, Stone MD. Assembly of complex RNAs by splinted ligation. Methods Enzymol. 2009;469:27–46. doi: 10.1016/S0076-6879(09)69002-9. [DOI] [PubMed] [Google Scholar]
  • 47.Suddala KC, Walter NG. Riboswitch structure and dynamics by smFRET microscopy. Methods Enzymol. 2014;549:343–373. doi: 10.1016/B978-0-12-801122-5.00015-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Soltis SM, et al. New paradigm for macromolecular crystallography experiments at SSRL: Automated crystal screening and remote data collection. Acta Crystallogr D Biol Crystallogr. 2008;64(Pt 12):1210–1221. doi: 10.1107/S0907444908030564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Weiss MS. Global indicators of X-ray data quality. J Appl Cryst. 2001;34:130–135. [Google Scholar]
  • 50.Karplus PA, Diederichs K. Linking crystallographic model and data quality. Science. 2012;336(6084):1030–1033. doi: 10.1126/science.1218231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Adams PD, et al. PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 2):213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.McCarty RM, Bandarian V. Biosynthesis of pyrrolopyrimidines. Bioorg Chem. 2012;43:15–25. doi: 10.1016/j.bioorg.2012.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Keel AY, Rambo RP, Batey RT, Kieft JS. A general strategy to solve the phase problem in RNA crystallography. Structure. 2007;15(7):761–772. doi: 10.1016/j.str.2007.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Aalberts DP, Nandagopal N. A two-length-scale polymer theory for RNA loop free energies and helix stacking. RNA. 2010;16(7):1350–1355. doi: 10.1261/rna.1831710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Emsley P, Cowtan K. Coot: Model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60(Pt 12 Pt 1):2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
  • 56.Cheatham TE, 3rd, Cieplak P, Kollman PA. A modified version of the Cornell et al. force field with improved sugar pucker phases and helical repeat. J Biomol Struct Dyn. 1999;16(4):845–862. doi: 10.1080/07391102.1999.10508297. [DOI] [PubMed] [Google Scholar]
  • 57.Pérez A, et al. Refinement of the AMBER force field for nucleic acids: Improving the description of alpha/gamma conformers. Biophys J. 2007;92(11):3817–3829. doi: 10.1529/biophysj.106.097782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Zgarbová M, et al. Refinement of the Cornell et al. nucleic acids force field based on reference quantum chemical calculations of glycosidic torsion profiles. J Chem Theory Comput. 2011;7(9):2886–2902. doi: 10.1021/ct200162x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Aytenfisu AH, Spasic A, Seetin MG, Serafini J, Mathews DH. Modified AMBER force field correctly models the conformational preference for tandem GA pairs in RNA. J Chem Theory Comput. 2014;10(3):1292–1301. doi: 10.1021/ct400861g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79(2):926–935. [Google Scholar]
  • 61.Joung IS, Cheatham TE., 3rd Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations. J Phys Chem B. 2008;112(30):9020–9041. doi: 10.1021/jp8001614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Joung IS, Cheatham TE., 3rd Molecular dynamics simulations of the dynamic and energetic properties of alkali and halide ions using water-model-specific ion parameters. J Phys Chem B. 2009;113(40):13279–13290. doi: 10.1021/jp902584c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Case DA, et al. AMBER. University of California; San Francisco: 2014. [Google Scholar]
  • 64.Bayly CI, Cieplak P, Cornell WD, Kollman PA. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model. J Phys Chem. 1993;97(40):10269–10280. [Google Scholar]
  • 65.Dupradeau FY, et al. The R.E.D. tools: Advances in RESP and ESP charge derivation and force field library building. Phys Chem Chem Phys. 2010;12(28):7821–7839. doi: 10.1039/c0cp00111b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Vanquelef E, et al. R.E.D. Server: A web service for deriving RESP and ESP charges and building force field libraries for new molecules and molecular fragments. Nucleic Acids Res. 2011;39(Web Server issue):W511-7. doi: 10.1093/nar/gkr288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Case DA, et al. The Amber biomolecular simulation programs. J Comput Chem. 2005;26(16):1668–1688. doi: 10.1002/jcc.20290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Qin F. Restoration of single-channel currents using the segmental k-means method based on hidden Markov modeling. Biophys J. 2004;86(3):1488–1501. doi: 10.1016/S0006-3495(04)74217-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Blanco M, Walter NG. Analysis of complex single-molecule FRET time trajectories. Methods Enzymol. 2010;472:153–178. doi: 10.1016/S0076-6879(10)72011-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Han K, Byun Y. PSEUDOVIEWER2: Visualization of RNA pseudoknots of any type. Nucleic Acids Res. 2003;31(13):3432–3440. doi: 10.1093/nar/gkg539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Terwilliger TC, et al. Iterative-build OMIT maps: Map improvement by iterative model building and refinement without model bias. Acta Crystallogr D Biol Crystallogr. 2008;64(Pt 5):515–524. doi: 10.1107/S0907444908004319. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES